Review



computer-generated randomisation codes  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Pfizer Inc computer-generated randomisation codes
    Computer Generated Randomisation Codes, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+list/pmc06483741-2243-40-10
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation codes - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
    Article Snippet: .. Unmasked personnel include the trial biostatistician and data analyst responsible for implementing the randomization sequence and key members of Pfizer staff responsible for implementation of the randomization sequence. ..

    Article Title: Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
    Article Snippet: .. Time to first relief: reported ‐ median time to first relief Costs: not assessed Notes Compliance checks: not specified Pharmaceutical industry support: yes ‐ Pfizer Central Research, Sandwich, England % follow‐up calculated based on number randomised Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Computer‐generated randomisation list, probably random. ..

    Article Title: Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
    Article Snippet: Dr Richardson is an employee of Eisai Inc. PPS International Communications (Worthing, UK) assisted in the development of the manuscript. .. Notes AD: Alzheimer's disease ADAS-Cog/11: Alzheimer's Disease Assessment Scale–Cognitive Subscale DAD: Disability Assessment for Dementia DSM-IV: The Diagnostic and Statistical Manual of Mental Disorders Fourth Edition MMSE: Mini-Mental State Examination NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association NPI: Neuropsychiatric Inventory Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was performed using a computer-generated randomisation list provided by Pfizer Inc Allocation concealment (selection bias) Unclear risk Methods used to conceal the allocation sequence were not described; therefore it was not possible to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment Blinding of participants and personnel (performance bias) All outcomes Unclear risk Blinding was implemented with identical film-coated tablets within a blister-packaged card. ..

    other:

    Article Title: Efficacy of a Fixed-Dose Combination of Ibuprofen and Acetaminophen Compared With Individual Monocomponents in Adult Male Subjects With Endotoxin-Induced Fever: A Randomized Controlled Trial.
    Article Snippet: Once a subject’s oral temperature reached ≥38.1 °C, he was randomized to treatment via a computer-generated randomization schedule generated and maintained by Pfizer and provided to the study site.

    Article Title: Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women
    Article Snippet: Steingrímsson 1994 mentioned that they used a computer‐generated random list provided by Pfizer (unclear risk).

    Article Title: Pregabalin add‐on for drug‐resistant focal epilepsy
    Article Snippet: Study was sponsored by Pfizer Inc. Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Used a computer‐generated randomised schedule using block sizes of 5.

    Article Title: Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women
    Article Snippet: Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Unclear risk Study authors mention “random assigned by use of a computer generated randomised list provided by Pfizer”.

    Selection:

    Article Title: Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
    Article Snippet: .. Time to first relief: reported ‐ median time to first relief Costs: not assessed Notes Compliance checks: not specified Pharmaceutical industry support: yes ‐ Pfizer Central Research, Sandwich, England % follow‐up calculated based on number randomised Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Computer‐generated randomisation list, probably random. ..

    Article Title: Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults
    Article Snippet: Background Depression and anxiety are the most frequent indication for which antidepressants are prescribed.. Long-term antidepressant use is driving much of the internationally observed rise in antidepressant consumption.. Surveys of antidepressant users suggest that 30% to 50% of long-term antidepressant prescriptions had no evidence-based indication.

    Article Title: Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
    Article Snippet: Dr Richardson is an employee of Eisai Inc. PPS International Communications (Worthing, UK) assisted in the development of the manuscript. .. Notes AD: Alzheimer's disease ADAS-Cog/11: Alzheimer's Disease Assessment Scale–Cognitive Subscale DAD: Disability Assessment for Dementia DSM-IV: The Diagnostic and Statistical Manual of Mental Disorders Fourth Edition MMSE: Mini-Mental State Examination NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association NPI: Neuropsychiatric Inventory Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was performed using a computer-generated randomisation list provided by Pfizer Inc Allocation concealment (selection bias) Unclear risk Methods used to conceal the allocation sequence were not described; therefore it was not possible to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment Blinding of participants and personnel (performance bias) All outcomes Unclear risk Blinding was implemented with identical film-coated tablets within a blister-packaged card. ..

    Diagnostic Assay:

    Article Title: Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
    Article Snippet: Dr Richardson is an employee of Eisai Inc. PPS International Communications (Worthing, UK) assisted in the development of the manuscript. .. Notes AD: Alzheimer's disease ADAS-Cog/11: Alzheimer's Disease Assessment Scale–Cognitive Subscale DAD: Disability Assessment for Dementia DSM-IV: The Diagnostic and Statistical Manual of Mental Disorders Fourth Edition MMSE: Mini-Mental State Examination NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association NPI: Neuropsychiatric Inventory Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was performed using a computer-generated randomisation list provided by Pfizer Inc Allocation concealment (selection bias) Unclear risk Methods used to conceal the allocation sequence were not described; therefore it was not possible to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment Blinding of participants and personnel (performance bias) All outcomes Unclear risk Blinding was implemented with identical film-coated tablets within a blister-packaged card. ..



    Similar Products

    computer generated randomisation code  (Cipla Inc)
    90
    Cipla Inc computer generated randomisation code
    Computer Generated Randomisation Code, supplied by Cipla Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc06485805-575-2-18
    Average 90 stars, based on 1 article reviews
    computer generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation codes  (Pfizer Inc)
    90
    Pfizer Inc computer-generated randomisation codes
    Computer Generated Randomisation Codes, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+list/pmc06483741-2243-40-10
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation codes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer‑generated randomisation code  (Boehringer Ingelheim)
    90
    Boehringer Ingelheim computer‑generated randomisation code
    Bateman 2010a
    Computer‑Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc08934583-115-16-20
    Average 90 stars, based on 1 article reviews
    computer‑generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Boehringer Ingelheim)
    90
    Boehringer Ingelheim computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc10879916-322-16-20
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Ferring Pharmaceuticals)
    90
    Ferring Pharmaceuticals computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation/pmc11422753-1997-29-6
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation codes  (Bayer Schering Pharma)
    90
    Bayer Schering Pharma computer-generated randomisation codes
    Bateman 2010a
    Computer Generated Randomisation Codes, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+codes/pm18395326-57-0-7
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation codes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer generated randomisation code  (Pharmacia Upjohn LLC)
    90
    Pharmacia Upjohn LLC computer generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/patches+with+randomization+numbers/pmc01920563-139-7-17
    Average 90 stars, based on 1 article reviews
    computer generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    computer-generated randomisation code  (Novartis)
    90
    Novartis computer-generated randomisation code
    Bateman 2010a
    Computer Generated Randomisation Code, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pm12765508-76-17-21
    Average 90 stars, based on 1 article reviews
    computer-generated randomisation code - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Bateman 2010a

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Bateman 2010a

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Medications, Clinical Proteomics, Sequencing, Selection

    Bateman 2010b

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Bateman 2010b

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

    Beeh 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Beeh 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Brusasco 2003

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Brusasco 2003

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Casaburi 2002

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Casaburi 2002

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Capsules

    Chan 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Chan 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Cooper 2010

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Cooper 2010

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Modification, Sequencing, Selection, Generated, Control

    Covelli 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Covelli 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Dusser 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Dusser 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Control

    Freeman 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Freeman 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated

    Johansson 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Johansson 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    Magnussen 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Magnussen 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

    Moita 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Moita 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

    NCT00144326

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: NCT00144326

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Activity Assay, Plasmid Preparation, Modification, Sequencing, Selection, Generated, Control

    Niewoehner 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Niewoehner 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated

    Powrie 2007

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Powrie 2007

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Concentration Assay, Sequencing, Selection, Generated, Control

    Tashkin 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Tashkin 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated

    Tonnel 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Tonnel 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay, Control

    Trooster 2011

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Trooster 2011

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Medications, Activity Assay, Sequencing, Selection, Generated, Control

    Verkinde 2006

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Verkinde 2006

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Infection, Modification, Sequencing, Selection, Generated, Control

    Voshaar 2008

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

    doi: 10.1002/14651858.CD009285.pub3

    Figure Lengend Snippet: Voshaar 2008

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

    Techniques: Biomarker Discovery, Sequencing, Selection, Generated

    Bateman 2010a

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Bateman 2010a

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Medications, Sequencing, Selection

    Brusasco 2003

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Brusasco 2003

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

    Calverley 2007 [TORCH]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Calverley 2007 [TORCH]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Western Blot, Biomarker Discovery, Solvent, Medications, Sequencing, Selection, Generated, Clinical Proteomics

    Niewoehner 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Niewoehner 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated, Modification

    Ohar 2013

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Ohar 2013

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection

    Ozol 2005

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Ozol 2005

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection, Generated

    Renkema 1996

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Renkema 1996

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Functional Assay, Clinical Proteomics, Sequencing, Selection

    Schermer 2009

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Schermer 2009

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Sequencing, Selection, Generated, Blocking Assay

    Tashkin 2008a [UPLIFT]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Tashkin 2008a [UPLIFT]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection

    Tonnel 2008 [TIPHON]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Tonnel 2008 [TIPHON]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay

    Vogelmeier 2011 [POET]

    Journal: The Cochrane Database of Systematic Reviews

    Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

    doi: 10.1002/14651858.CD010844.pub2

    Figure Lengend Snippet: Vogelmeier 2011 [POET]

    Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

    Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Blocking Assay, Capsules